Tango Therapeutics, Inc. (TNGX): Volume dodolan mangsa ngarep perusahaan

Logo grafis Tango Therapeutics, Inc. (TNGX)

Geopolitical tensions and sanctions are hindering the biomaterials logistics of Tango Therapeutics (TNGX). The core of the business is a biopharmaceutical targeted oncology network that creates patent perimeters through partnerships with industry behemoths. The company's promising sales volume confirms this scale, with the latest figure standing at 0.00. Research and development rely on CRISPR screening to create precision therapies against solid tumors.

Prakiraan pendapatan perusahaan: Tango Therapeutics (TNGX) kanggo 04.07.2022 - 16.11.2026

TNGX (Tango Therapeutics): rincian analitis lan laporan miturut indikator

- nilai saham lan prakiraan konsensus rega:
Ringkesan analisis perusahaan:Tango Therapeutics, Inc.
Sampel barang Tango Therapeutics Corp

This metric aggregates the impact of operating flows on projected revenue, transforming fundamental expectations into the business's market value. For Tango Therapeutics (TNGX), whose strategy is based on the pricing power of targeted drugs, changes in future sales volumes reflect capital confidence in the commercialization of unique treatments for rare mutations, allowing investors to timely identify the asset's undervaluation point.

Pesaing langsung

Prakiraan pendapatan perusahaan ImmunityBio Inc (IBRX)|Volume dodolan mangsa ngarep perusahaan Immunocore PLC IMCR|Janux Therapeutics Inc - Volume dodolan mangsa ngarep perusahaan|Prakiraan volume dodolan Arcus Corp RCUS|ZYME - Prakiraan pendapatan perusahaan|IOVA (iovance.com) - Prakiraan pendapatan perusahaan|Immatics Biotechnologies (IMTX) - Prakiraan pendapatan perusahaan|Volume dodolan sing dikarepake perusahaan Xencor Corp (XNCR)|Volume dodolan mangsa ngarep perusahaan CMPX|REPL - Prakiraan dodolan perusahaan|Volume dodolan mangsa ngarep perusahaan LYEL (Lyell Immunopharma Inc)|Prakiraan volume pendapatan perusahaan IPHA|Prakiraan volume dodolan PYXS (Pyxis Oncology, Inc.)|Pendapatan mangsa ngarep perusahaan CGEN|iobiotech.com - Prakiraan volume dodolan|Volume dodolan sing dikarepake perusahaan Sutro Biopharma, Inc|MiNK Therapeutics, Inc. (INKT) - Prakiraan pendapatan perusahaan|Werewolf Therapeutics Inc. - Pendapatan mangsa ngarep perusahaan|IMMX (Immix) - Prakiraan volume dodolan|Prakiraan volume dodolan ALX Oncology Holdings Inc.|Volume dodolan mangsa ngarep perusahaan CUE (Cue Biopharma Inc.)|PDSB: Pendapatan sing dikarepake perusahaan|Sonnet BioTherapeutics Holdings - Volume dodolan mangsa ngarep perusahaan|MAIABiotech.com (MAIA) - Volume dodolan sing dikarepake perusahaan|LIMN - Prakiraan pendapatan perusahaan|LVTX: Prakiraan pendapatan perusahaan|NXTC: Prakiraan volume dodolan|Volume dodolan sing dikarepake perusahaan Leap Therapeutics Inc (LPTX)|Volume dodolan mangsa ngarep perusahaan INTS|Prakiraan pendapatan perusahaan SNSE (senseibio.com)|Prakiraan pendapatan perusahaan Theriva Biologics (TOVX)|Prakiraan volume pendapatan perusahaan GRTS|Kineta Bio - Volume dodolan mangsa ngarep perusahaan|NEXI - Volume dodolan mangsa ngarep perusahaan|TSBX: Volume dodolan mangsa ngarep perusahaan|VCNX (Vaccinex, Inc.) - Prakiraan pendapatan perusahaan|Harpoon Tx (HARP) - Prakiraan pendapatan perusahaan